DK0703913T3 - Imidazoler som lipoxygenaseinhibitorer - Google Patents
Imidazoler som lipoxygenaseinhibitorerInfo
- Publication number
- DK0703913T3 DK0703913T3 DK94916398.4T DK94916398T DK0703913T3 DK 0703913 T3 DK0703913 T3 DK 0703913T3 DK 94916398 T DK94916398 T DK 94916398T DK 0703913 T3 DK0703913 T3 DK 0703913T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- substituted
- independently
- alkoxy
- halo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14220693 | 1993-06-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0703913T3 true DK0703913T3 (da) | 1997-10-20 |
Family
ID=15309865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94916398.4T DK0703913T3 (da) | 1993-06-14 | 1994-05-25 | Imidazoler som lipoxygenaseinhibitorer |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5753682A (cs) |
| EP (1) | EP0703913B1 (cs) |
| KR (1) | KR100190728B1 (cs) |
| CN (2) | CN1050840C (cs) |
| AT (1) | ATE154353T1 (cs) |
| AU (1) | AU685122B2 (cs) |
| BR (1) | BR9406822A (cs) |
| CA (1) | CA2163667C (cs) |
| CZ (1) | CZ282969B6 (cs) |
| DE (1) | DE69403795T2 (cs) |
| DK (1) | DK0703913T3 (cs) |
| ES (1) | ES2103130T3 (cs) |
| FI (1) | FI942792A7 (cs) |
| GR (1) | GR3024568T3 (cs) |
| HU (1) | HUT70767A (cs) |
| IL (1) | IL109903A (cs) |
| NO (1) | NO955046L (cs) |
| NZ (1) | NZ266541A (cs) |
| PL (2) | PL176522B1 (cs) |
| RU (1) | RU2126004C1 (cs) |
| TW (1) | TW374088B (cs) |
| WO (1) | WO1994029299A1 (cs) |
| ZA (1) | ZA944140B (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063928A (en) * | 1994-10-18 | 2000-05-16 | Pfizer Inc | 5-lipoxygenase inhibitors |
| US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
| SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
| DK0863905T3 (da) | 1995-09-18 | 2001-01-02 | Pfizer | Imidazollipoxygenaseinhibitorer |
| TR200003137T2 (tr) * | 1998-04-29 | 2001-02-21 | The Procter & Gamble Company | 1,3-İki defa yer değiştirmiş-4-oksosiklik üreler |
| US6420568B1 (en) * | 1998-04-29 | 2002-07-16 | The Procter & Gamble Company | Process for making 1,3-disubstituted-4-oxocyclic ureas |
| US6194585B1 (en) * | 1998-12-22 | 2001-02-27 | Pfizer Inc. | Process for preparing 5-lipoxygenase inhibitors |
| US6344563B1 (en) * | 1999-08-31 | 2002-02-05 | Timothy Norris | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| BRPI0718672A2 (pt) | 2006-11-27 | 2013-11-26 | Pfizer Prod Inc | Análogos de pirazol |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1183847A (en) * | 1981-10-01 | 1985-03-12 | Georges Van Daele | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
| EP0106440B1 (en) * | 1982-08-12 | 1987-11-25 | Smith and Nephew Associated Companies p.l.c. | Wound dressing and its manufacture |
| JPS60142966A (ja) * | 1983-09-05 | 1985-07-29 | Yoshitomi Pharmaceut Ind Ltd | イミダゾ−ル誘導体 |
| US4851526A (en) * | 1987-09-04 | 1989-07-25 | Schering A.G. | 1-(4-Substituted phenyl)-1H-imidazoles compounds |
| US5234950A (en) * | 1988-12-23 | 1993-08-10 | Imperial Chemical Industries Plc | Tetrahydrofuran derivatives |
| GB8926981D0 (en) * | 1988-12-23 | 1990-01-17 | Ici Plc | Heterocyclic derivatives |
| US5223525A (en) * | 1989-05-05 | 1993-06-29 | Rhone-Poulenc Ag Company | Pesticidal 1-arylimidazoles |
| IE64358B1 (en) * | 1989-07-18 | 1995-07-26 | Ici Plc | Diaryl ether heterocycles |
| IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
| GB9101375D0 (en) * | 1991-01-22 | 1991-03-06 | Erba Carlo Spa | N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole |
| GB9108811D0 (en) * | 1991-04-24 | 1991-06-12 | Erba Carlo Spa | N-imidazolyl derivatives of substituted indole |
-
1994
- 1994-05-25 PL PL94326494A patent/PL176522B1/pl unknown
- 1994-05-25 WO PCT/JP1994/000836 patent/WO1994029299A1/en not_active Ceased
- 1994-05-25 DK DK94916398.4T patent/DK0703913T3/da active
- 1994-05-25 CA CA002163667A patent/CA2163667C/en not_active Expired - Fee Related
- 1994-05-25 KR KR1019950705659A patent/KR100190728B1/ko not_active Expired - Fee Related
- 1994-05-25 AT AT94916398T patent/ATE154353T1/de not_active IP Right Cessation
- 1994-05-25 NZ NZ266541A patent/NZ266541A/en unknown
- 1994-05-25 ES ES94916398T patent/ES2103130T3/es not_active Expired - Lifetime
- 1994-05-25 CN CN94192439A patent/CN1050840C/zh not_active Expired - Fee Related
- 1994-05-25 US US08/553,546 patent/US5753682A/en not_active Expired - Fee Related
- 1994-05-25 DE DE69403795T patent/DE69403795T2/de not_active Expired - Fee Related
- 1994-05-25 AU AU68077/94A patent/AU685122B2/en not_active Ceased
- 1994-05-25 RU RU96100073A patent/RU2126004C1/ru active
- 1994-05-25 CZ CZ953276A patent/CZ282969B6/cs not_active IP Right Cessation
- 1994-05-25 PL PL94312006A patent/PL175987B1/pl unknown
- 1994-05-25 EP EP94916398A patent/EP0703913B1/en not_active Expired - Lifetime
- 1994-05-25 BR BR9406822A patent/BR9406822A/pt not_active Application Discontinuation
- 1994-05-30 TW TW083104929A patent/TW374088B/zh active
- 1994-06-06 IL IL10990394A patent/IL109903A/en not_active IP Right Cessation
- 1994-06-13 HU HU9401762A patent/HUT70767A/hu unknown
- 1994-06-13 ZA ZA944140A patent/ZA944140B/xx unknown
- 1994-06-13 FI FI942792A patent/FI942792A7/fi unknown
-
1995
- 1995-12-13 NO NO955046A patent/NO955046L/no unknown
-
1997
- 1997-08-28 GR GR970402207T patent/GR3024568T3/el unknown
-
1999
- 1999-06-10 CN CN99108414A patent/CN1247191A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950704228A (ko) | 선택적 포스포디에스테르가수분해효소 iv형(pde_iv) 저해제로서의 카테콜 디에테르(catecol diethers as selective pde_iv inhibitors) | |
| BR9916282A (pt) | Composto, uso de um um composto e método de tratamento | |
| WO1999033858A3 (en) | Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use | |
| NO955046D0 (no) | Imidazol-lipogenase-inhibitorer | |
| BR9913654A (pt) | Inibidores de p-38alfa quinase | |
| KR920006322A (ko) | 벤젠, 피리딘 및 피리미딘 유도체 | |
| AR008614A1 (es) | UN PROCEDIMIENTO PARA LA FABRICACIoN DE UNA COMPOSICION FARMACEUTICA QUE CONTIENE UN COMPUESTO DE PIRIMIDINA O UNA SAL FARMACEUTICAMENTE ACEPTABLE DELMISMO, QUE TIENE ACTIVIDAD INHIBITORIA DE LA TIROSINA QUINASA, COMPUESTOS DE PIRIMIDINA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y UN PROCEDIMI | |
| FR2705343B1 (fr) | Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique. | |
| ID26622A (id) | Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide | |
| AR001061A1 (es) | Composición fungicida sinergica procedimiento par a combatir hongos nocivos uso de los compuestos que integran dicha composición como componentes sinergicos de la misma | |
| BR9912684A (pt) | Composto de fórmula (i), composição farmacêutica compreendendo o composto, método, processo e seu uso | |
| WO2003022797A1 (en) | Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient | |
| PT91435A (pt) | Processo para a preparacao de aril-alquil-aminas e -amidas possuindo propriedades anticonvulsivas e neuroprotectoras e de composicoes farmaceuticas que as contem | |
| BR9910206A (pt) | Derivados de higromicina a. | |
| NZ501694A (en) | Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives | |
| NZ512934A (en) | Synergistic fungicidal mixture of a 4-phenoxy-quinoline derivative and a 1,2-diazole carbamate derivative or 1,2,4-triazole carbamate derivative | |
| BR0014759A (pt) | Inibidores de metaloprotease beta dissubstituìdos | |
| ATE278676T1 (de) | Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren | |
| DE59604901D1 (de) | Carbamoylcarbonsäureamide | |
| WO2002026708A1 (en) | Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient | |
| BR0206385A (pt) | Mistura fungicida e método para combater fungos nocivos | |
| NZ505547A (en) | Synergistic fungicide mixtures based on amide compounds and pyridine or oxime derivatives | |
| BR0116240A (pt) | Mistura fungicida, método para controlar fungos nocivos, e, usos dos compostos de amida e dos derivados de imidazol | |
| DK0710233T3 (da) | Heteroarylcycloalkenylhydroxyurinstoffer | |
| DE69910738D1 (de) | Fungizide zusammensetzung enthaltend ein n-benzoyl-n'-phenyl-harnstoff derivat |